NEW YORK (GenomeWeb) – The University of Maryland, Baltimore and the University of Maryland, College Park have granted molecular diagnostics firm Cellth Systems an exclusive license to commercially develop a cell-tethering technology that allows for real-time analysis of circulating tumor cells.

Cellth also said today that TEDCO has awarded it $150,000 through the Maryland Innovation Initiative program, which will help advance the device toward commercialization.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.